{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:45:48Z","timestamp":1788306348034,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00467-017-3627-2","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T10:49:17Z","timestamp":1489056557000},"page":"1433-1442","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients"],"prefix":"10.1007","volume":"32","author":[{"given":"Elisa","family":"Colombini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Guzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Morolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germana","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Barzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Murer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Luisa","family":"Ciofi degli Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Dello Strologo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"3627_CR1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00467-007-0582-3","volume":"24","author":"VR Dharnidharka","year":"2009","unstructured":"Dharnidharka VR, Araya CE (2009) Post-transplant lymphoproliferative disease. Pediatr Nephrol 24:731\u2013736","journal-title":"Pediatr Nephrol"},{"key":"3627_CR2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TP.0b013e318269e64f","volume":"94","author":"D Glotz","year":"2012","unstructured":"Glotz D, Chapman JR, Dharnidharka VR, Hanto DW, Castro MC, Hirsch HH, Leblond V, Mehta AK, Moulin B, Pagliuca A, Pascual J, Rickinson AB, Russo FP, Trappe RU, Webster AC, Zuckermann AO, Gross TG (2012) The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation 94:784\u2013793","journal-title":"Transplantation"},{"key":"3627_CR3","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfq231","volume":"25","author":"K Mucha","year":"2010","unstructured":"Mucha K, Foroncewicz B, Ziarkiewicz-Wroblewska B, Krawczyk M, Lerut J, Paczek L (2010) Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease? Nephrol Dial Transplant 25:2089\u20132098","journal-title":"Nephrol Dial Transplant"},{"key":"3627_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2141.2010.08161.x","volume":"149","author":"A Parker","year":"2010","unstructured":"Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C (2010) Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients\u2014BCSH and BTS Guidelines. Br J Haematol 149:675\u2013692","journal-title":"Br J Haematol"},{"key":"3627_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-3046.2005.00318.x","volume":"9","author":"UD Allen","year":"2005","unstructured":"Allen UD, Farkas G, Hebert D, Weitzman S, Stephens D, Petric M, Tellier R, Ngan B, Fecteau A, West L, Wasfy S (2005) Risk factors for post-transplant lymphoproliferative disorder in pediatric patients: a case-control study. Pediatr Transplant 9:450\u2013455","journal-title":"Pediatr Transplant"},{"key":"3627_CR6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1442-200X.2008.02579.x","volume":"50","author":"T Sato","year":"2008","unstructured":"Sato T, Fujieda M, Tanaka E, Miyamura M, Chikamoto H, Hisano M, Akioka Y, Ishiura Y, Dohno S, Maeda A, Hattori M, Wakiguchi H (2008) Monitoring of Epstein\u2013Barr virus load and antibody in pediatric renal transplant patients. Pediatr Int 50:454\u2013458","journal-title":"Pediatr Int"},{"key":"3627_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jmv.23493","volume":"85","author":"A Biasiolo","year":"2013","unstructured":"Biasiolo A, Tono N, Zaninotto M, Merkel C, Fassina G, Plebani M, Gatta A, Pontisso P (2013) Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity. J Med Virol 85:1005\u20131008","journal-title":"J Med Virol"},{"issue":"Suppl 3","key":"3627_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajt.12004","volume":"13","author":"M Green","year":"2013","unstructured":"Green M, Michaels MG (2013) Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 13(Suppl 3):41\u201354","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"3627_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/ajt.12104","volume":"13","author":"UD Allen","year":"2013","unstructured":"Allen UD, Preiksaitis JK (2013) Epstein\u2013Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 13[Suppl 4]:107\u2013120","journal-title":"Am J Transplant"},{"key":"3627_CR10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2214\/AJR.04.1546","volume":"185","author":"GE Wilde","year":"2005","unstructured":"Wilde GE, Moore DJ, Bellah RD (2005) Posttransplantation lymphoproliferative disorder in pediatric recipients of solid organ transplants: timing and location of disease. AJR Am J Roentgenol 185:1335\u20131341","journal-title":"AJR Am J Roentgenol"},{"key":"3627_CR11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1399-3046.2007.00738.x","volume":"11","author":"T Suzuki","year":"2007","unstructured":"Suzuki T, Ikezumi Y, Okubo S, Uchiyama M, Takahashi K, Shiraga H, Hattori M (2007) Epstein\u2013Barr virus DNA load and seroconversion in pediatric renal transplantation with tacrolimus immunosuppression. Pediatr Transplant 11:749\u2013754","journal-title":"Pediatr Transplant"},{"key":"3627_CR12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1600-6143.2008.02167.x","volume":"8","author":"RA McDonald","year":"2008","unstructured":"McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, Wyatt R, Arar M, Liereman D, Bridges N, Harmon W (2008) Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant 8:984\u2013989","journal-title":"Am J Transplant"},{"key":"3627_CR13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-6143.2007.02080.x","volume":"8","author":"MA Bingler","year":"2008","unstructured":"Bingler MA, Feingold B, Miller SA, Quivers E, Michaels MG, Green M, Wadowsky RM, Rowe DT, Webber SA (2008) Chronic high Epstein\u2013Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease\/lymphoma in children. Am J Transplant 8:442\u2013445","journal-title":"Am J Transplant"},{"key":"3627_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5414\/CN106572","volume":"76","author":"M Ishihara","year":"2011","unstructured":"Ishihara M, Tanaka E, Sato T, Chikamoto H, Hisano M, Akioka Y, Dohno S, Maeda A, Hattori M, Wakiguchi H, Fujieda M (2011) Epstein\u2013Barr virus load for early detection of lymphoproliferative disorder in pediatric renal transplant recipients. Clin Nephrol 76:40\u201348","journal-title":"Clin Nephrol"},{"key":"3627_CR15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-3046.2010.01465.x","volume":"15","author":"E Tanaka","year":"2011","unstructured":"Tanaka E, Sato T, Ishihara M, Tsutsumi Y, Hisano M, Chikamoto H, Akioka Y, Dohno S, Maeda A, Hattori M, Wakiguchi H, Fujieda M (2011) Asymptomatic high Epstein\u2013Barr viral load carriage in pediatric renal transplant recipients. Pediatr Transplant 15:306\u2013313","journal-title":"Pediatr Transplant"},{"key":"3627_CR16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/bmt.2013.170","volume":"49","author":"CP Fox","year":"2014","unstructured":"Fox CP, Burns D, Parker AN, Peggs KS, Harvey CM, Natarajan S, Marks DI, Jackson B, Chakupurakal G, Dennis M, Lim Z, Cook G, Carpenter B, Pettitt AR, Mathew S, Connelly-Smith L, Yin JA, Viskaduraki M, Chakraverty R, Orchard K, Shaw BE, Byrne JL, Brookes C, Craddock CF, Chaganti S (2014) EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era. Bone Marrow Transplant 49:280\u2013286","journal-title":"Bone Marrow Transplant"},{"key":"3627_CR17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.TP.0000438629.13967.16","volume":"97","author":"S Ruf","year":"2014","unstructured":"Ruf S, Behnke-Hall K, Gruhn B, Reiter A, Wagner HJ (2014) EBV load in whole blood correlates with LMP2 gene expression after pediatric heart transplantation or allogeneic hematopoietic stem cell transplantation. Transplantation 97:958\u2013964","journal-title":"Transplantation"},{"key":"3627_CR18","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein\u2013Barr virus infection. N Engl J Med 343:481\u2013492","journal-title":"N Engl J Med"},{"key":"3627_CR19","doi-asserted-by":"crossref","unstructured":"Van Arendonk KJ, King EA, Orandi BJ, James NT, Smith JM, Colombani PM, Magee JC, Segev DL (2015) Loss of pediatric kidney grafts during the \"high-risk age window\": insights from pediatric liver and simultaneous liver\u2013kidney recipients. Am J Transplant 15:445\u2013452","DOI":"10.1111\/ajt.12985"},{"key":"3627_CR20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2215\/CJN.10311012","volume":"8","author":"KJ Arendonk Van","year":"2013","unstructured":"Van Arendonk KJ, James NT, Boyarsky BJ, Garonzik-Wang JM, Orandi BJ, Magee JC, Smith JM, Colombani PM, Segev DL (2013) Age at graft loss after pediatric kidney transplantation: exploring the high-risk age window. Clin J Am Soc Nephrol 8:1019\u20131026","journal-title":"Clin J Am Soc Nephrol"},{"key":"3627_CR21","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.2215\/CJN.03760411","volume":"6","author":"KJ Arendonk Van","year":"2011","unstructured":"Van Arendonk KJ, James NT, Locke JE, Montgomery RA, Colombani PM, Segev DL (2011) Late graft loss among pediatric recipients of DCD kidneys. Clin J Am Soc Nephrol 6:2705\u20132711","journal-title":"Clin J Am Soc Nephrol"},{"key":"3627_CR22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1432-2277.2012.01485.x","volume":"25","author":"B Hocker","year":"2012","unstructured":"Hocker B, Bohm S, Fickenscher H, Kusters U, Schnitzler P, Pohl M, John U, Kemper MJ, Fehrenbach H, Wigger M, Holder M, Schroder M, Feneberg R, Kopf-Shakib S, Tonshoff B (2012) (Val-)Ganciclovir prophylaxis reduces Epstein\u2013Barr virus primary infection in pediatric renal transplantation. Transpl Int 25:723\u2013731","journal-title":"Transpl Int"},{"key":"3627_CR23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/lt.21498","volume":"14","author":"L Hierro","year":"2008","unstructured":"Hierro L, Diez-Dorado R, Diaz C, De la Vega A, Frauca E, Camarena C, Munoz-Bartolo G, de Gonzalez ZA, Lopez SM, Jara P (2008) Efficacy and safety of valganciclovir in liver-transplanted children infected with Epstein\u2013Barr virus. Liver Transpl 14:1185\u20131193","journal-title":"Liver Transpl"},{"key":"3627_CR24","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood-2014-01-553362","volume":"124","author":"I Ricciardelli","year":"2014","unstructured":"Ricciardelli I, Blundell MP, Brewin J, Thrasher A, Pule M, Amrolia PJ (2014) Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells. Blood 124:2514\u20132522","journal-title":"Blood"},{"key":"3627_CR25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/cid\/cis823","volume":"56","author":"B Hocker","year":"2013","unstructured":"Hocker B, Fickenscher H, Delecluse HJ, Bohm S, Kusters U, Schnitzler P, Pohl M, John U, Kemper MJ, Fehrenbach H, Wigger M, Holder M, Schroder M, Billing H, Fichtner A, Feneberg R, Sander A, Kopf-Shakib S, Susal C, Tonshoff B (2013) Epidemiology and morbidity of Epstein\u2013Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study. Clin Infect Dis 56:84\u201392","journal-title":"Clin Infect Dis"},{"key":"3627_CR26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cid\/cit391","volume":"57","author":"J Styczynski","year":"2013","unstructured":"Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara RL, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S (2013) Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Clin Infect Dis 57:794\u2013802","journal-title":"Clin Infect Dis"},{"key":"3627_CR27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/TP.0000000000000487","volume":"99","author":"ME Lustberg","year":"2014","unstructured":"Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA (2014) Human leukocyte antigen type and posttransplant lymphoproliferative disorder. Transplantation 99:1220\u20131225","journal-title":"Transplantation"},{"key":"3627_CR28","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/ajt.12328","volume":"13","author":"S Furukawa","year":"2013","unstructured":"Furukawa S, Wei L, Krams SM, Esquivel CO, Martinez OM (2013) PI3Kdelta inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein\u2013Barr virus (EBV) + B cell lymphomas. Am J Transplant 13:2035\u20132043","journal-title":"Am J Transplant"}],"updated-by":[{"DOI":"10.1007\/s00467-017-3752-y","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T00:00:00Z","timestamp":1499644800000}}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3627-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3627-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T07:24:00Z","timestamp":1498116240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3627-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["3627"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3627-2","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00467-017-3752-y","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]}}}